NCT07445438
- Conditions
- Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +19 more
- Locations
-
- University of Parma Parma, PR, Italy
Clinical trial condition
Myeloma Multiple
Explore clinical trials studying Myeloma Multiple. Study availability and eligibility vary by location and protocol.
31 public trials
17 recruiting studies
Myeloma Multiple trial results
NCT04268199
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
NCT07236021
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Institut Jules Bordet, Hôpital universitaire de Bruxelles Brussels, Anderlecht, Belgium
- H.U.B Institut Jules Bordet Brussels, Brussels Capital, Belgium
Recruiting
Limited-duration Teclistamab
NCT05932680
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Columbia University New York, United States
- Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States
Recruiting
Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients
NCT06133426
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Cochin Hospital Paris, France
Recruiting
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
NCT06911710
- Conditions
- AML (Acute Myelogenous Leukemia), B-ALL, Blood Protein Disorders, +23 more
- Locations
-
- TianJin China. TianJin Medical University General Tianjin, Tianjin Municipality, China
NCT06245629
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Akademiska sjukhuset Uppsala, Sweden
Not Yet Recruiting
A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma
NCT07612787
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Centre Hospitalier Universitaire Amiens, France
- Centre Hospitalier Universitaire Angers, France
- Centre Hospitalier Universitaire Annecy, France
- Centre Hospitalier D'Argenteuil Argenteuil, France
Not Yet Recruiting
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
NCT07600151
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University Medical Center Hamburg-Eppendorf Hamburg, Germany
Not Yet Recruiting
Bioequivalence Studies of Dasatinib 100 Mg
NCT05944783
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- CAIMED Chía, Cundinamarca, Colombia